Isabelle Freiling, PhD, Nicole M. Krause, MA, and Dietram A. Scheufele, PhD
Misinformation is an urgent new problem, so health professions communities need solutions as much as they need to be wary of ethical pitfalls of rushed interventions.
AMA J Ethics. 2023; 25(3):E228-237. doi:
10.1001/amajethics.2023.228.
Dr Carmen Black joins Ethics Talk to discuss her article, coauthored with Dr Amanda Calhoun: “How Biased and Carceral Responses to Persons With Mental Illness in Acute Medical Care Settings Constitute Iatrogenic Harms.”
Abigail E. Lowe joins Ethics Talk to discuss her article, coauthored with Dr Shawn G. Gibbs: “How Should Health Care Organizations Protect Personnel in Environmental Services and Related Fields?”
Lloyd Duplechan joins Ethics Talk to discuss his article, coauthored with Dr David Sine: “Roles of Environmental Services Workers’ Wages and Status in Patient Safety.”
Sharon Griswold, MD, MPH, Mustfa K. Manzur, MD, MPH, MS, and Wendy Dean, MD
Practice ownership shifts to various employment models have amplified the problem of physician-employees of some US health care companies not knowing about services billed in their names.
AMA J Ethics. 2022; 24(11):E1049-1055. doi:
10.1001/amajethics.2022.1049.
More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline.
AMA J Ethics. 2022; 24(11):E1069-1074. doi:
10.1001/amajethics.2022.1069.
Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.
AMA J Ethics. 2022; 24(11):E1075-1082. doi:
10.1001/amajethics.2022.1075.
Sarosh Nagar, Leah Z. Rand, PhD, and Aaron S. Kesselheim, MD, JD, MPH
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.
AMA J Ethics. 2022; 24(11):E1083-1090. doi:
10.1001/amajethics.2022.1083.